![]() | |
Supplier Name | MedChemExpress (MCE) |
Contact | sales |
Tel | 609-228-6898 |
Mobile | 609-228-6898 |
sales@medchemexpress.com; tech@medchemexpress.com | |
Website | https://www.medchemexpress.com/ |
Product Name | Enoticumab |
Synonyms | Enoticumab |
CAS | 1192578-27-0 |
EINECS | |
Chemical Formula | |
Molecular Weight | |
inchi | |
Package | 1 mg;5 mg |
Price | Email to quote |
Descriptions | Enoticumab MedChemExpress (MCE) HY-P99925 REGN421 99.64% Please store the product under the recommended conditions in the Certificate of Analysis. Shipping with dry ice. Enoticumab (REGN421, SAR153192) is an IgG1κ antibody targeting human Dll4. DLL4 is a ligand of the Notch signaling pathway and regulates fatty acid uptake through non-transcriptional regulation of macropinocytosis-dependent long-chain fatty acid uptake. Specific in vivo activity of Enoticumab in an ovarian xenograft model. EGN421 (2.5 mg/kg once weekly) resulted in 86% and 83% tumor growth inhibition in mouse subcutaneous TOV-112D or intraperitoneal A2780 human tumor xenograft models, respectively. Human Human IgG1 kappa Human IgG1 kappa, Isotype Control |
Last Update | 2025-04-01 14:45:47 |